FP6 Rare Disease Project Listing


At a Glance
  • Status: Completed Consortium
  • Year Launched: 2002
  • Initiating Organization: European Commission Sixth Framework Programme (FP6)
  • Initiator Type: Government
  • Rare disease
  • Disease focus:
  • Location: Europe

Abstract

FP6 Rare Disease Projects aim to develop a database of rare diseases, which includes:  disease name, year of database entry, and description-- ultimately working toward furthering research that could potentially aid in the treatment of documented diseases.

Mission

The consortium database acts as a resource for collaboration on research that can affect the listed diseases.  By compiling this database, information on rare diseases that may be difficult to come by or find are made easily accessible.  Researchers searching for current or formed data on these rare diseases are able to use the list for networking capabilities.  

Consortium History

As this consortium is a compiled database, each link within the system has its’ own history

Structure & Governance

FP6 (Sixth Framework Programme) Rare Disease Project is commissioned by CORDIS (Community Research and Development Information Service), which is a program of the European Commission and therefore the European Union

Financing

Financed by the European Union FP6 Programme

Points of Contact

http://cordis.europa.eu/lifescihealth/major/rare-diseases-projects-1.htm

Sponsors & Partners

For a list of FP6 Rare Disease Project links, click here


Last Updated: 06/20/2017

The Consortia-pedia Catalogue is a living resource, and we are always adding new consortia. Provide information here about your collaboration to apply to be included in the Catalogue.

All the information contained in the Consortia-pedia was collected from publically available sources. Decisions to include or exclude a particular listing from Consortia-pedia were also made on the basis of publically available information and the criteria outlined in the FAQs. This site is intended to be an objective resource for the community, and inclusion does not constitute or imply endorsement, recommendation, or approval by FasterCures or the Milken Institute.